|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/38 | (2006.01) |
| A61K 31/727 | (2013.01) | ||
| A61K 31/727 | (2006.01) | ||
| A61K 38/57 | (2013.01) | ||
| A61K 35/16 | (2015.01) | ||
| C12Y 304/21027 | (2013.01) | ||
| A61K 38/385 | (2013.01) | ||
| A61K 38/57 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| C12Y 304/21038 | (2013.01) | ||
| A61P 7/02 | (2006.01) | ||
| C12Y 304/21008 | (2013.01) | ||
| A61P 9/06 | (2006.01) | ||
| A61K 35/16 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 11/08 | (2006.01) | ||
| A61P 11/08 | (2018.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 9/06 | (2018.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Number of the document | 3260124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17181203.5 |
| Date of filing the European patent application | 2012-05-14 | |
| (97) | Date of publication of the European application | 2017-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11165869 | 2011-05-12 | EP | |
| 201161487205 P | 2011-05-17 | US |
| (72) |
Schulte, Stefan , DE
Kalina, Uwe , DE
Moses, Michael , DE
Feussner, Annette , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS |
| METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS |